Five activist campaigns surfaced in SEC filings this week, marking a tactical shift downmarket. Miami International Holdings, Nathan's Famous, MeiraGTx Holdings, Monro, and Primis Financial—none with enterprise values above $2 billion—each drew 13D or 13G disclosures from separate activist investors. The filings represent a widening of the activist aperture beyond the twenty-name roster that typically absorbs institutional attention.
Miami International Holdings operates options exchanges and clearing infrastructure; Nathan's Famous runs a 143-unit franchise model built on a single product line; MeiraGTx develops gene therapies in ophthalmology and neurology; Monro operates 1,200 automotive service centers; Primis Financial is a $2.1 billion-asset community bank holding company. The common thread is modest float, defensible niches, and balance sheets that permit re-allocation without requiring consortium capital. All five trade below $500 million in market capitalization, a segment where activist economics tighten but competition for attention thins.
The timing follows a first quarter in which activist assets under management crossed $240 billion globally, according to data compiled through March. Larger funds have historically avoided sub-$1 billion targets due to position-sizing constraints and liquidity friction. But a cohort of newer vehicles—many structured as evergreen or semi-liquid funds—now treats the $300 million to $1.5 billion market-cap band as primary hunting ground. The math works when deployment pace matters more than headline IRR: a 15% position in a $400 million company requires $60 million, manageable for funds in the $500 million to $1 billion AUM range that emerged post-2020.
For allocators, the extension matters less for the individual names than for the signaling around activist capacity. If five campaigns surface simultaneously in this tier, the implication is that another twelve to eighteen are in diligence or pre-filing conversation. Small-cap activist activity historically clusters; the 2016 and 2019 waves both featured 30+ sub-$1 billion filings within six-month windows. The current velocity suggests similar cadence. Restaurant concepts with aging franchisee bases, regional financials trading below tangible book, and clinical-stage biotechs with platform assets all fit the archetype.
Operators should expect follow-on filings in healthcare services, regional banking, and industrial distribution over the next 90 days. The activist cohort targeting this segment typically moves from filing to board engagement within 45 days, then escalates or exits by the six-month mark. For allocators, liquidity events in small-cap activist situations remain binary: either strategic acquisition within twelve months or quiet exit once the thesis stalls. The five names disclosed this week will clarify which outcome applies by mid-year earnings.
The Nathan's Famous filing is worth isolating. A $400 million market-cap company with $140 million in annual revenue and a brand that hasn't required repositioning since 1916 is not a turnaround candidate. It's a royalty stream with unused optionality in licensing and unit expansion. That's the profile activists now consider addressable in a segment previously left to family offices and microcap long-only funds.